Skip to content

PolitiKit

David Goodman's lobbying: the registrations they file and every meeting they've reported since November 2021.

← Lobbying

Registrant (responsible officer)

David Goodman

Chief Executive Officer

For companies and organizations, the most senior paid officer files the registration and the monthly reports, whoever attended the meeting.

Meetings this Parliament
175
Since Nov 2021
205
Active registrations
1

Reported meetings

  • Pharmascience Inc.
    • Doug Forsyth · Directeur général, Global Affairs Canada (GAC)
    • Ryan Schmelzle · Directeur adjoint, Global Affairs Canada (GAC)
    • Callie Stewart · Directeur exécutif, Global Affairs Canada (GAC)
    • Jean-Sébastien Nadon · Directeur adjoint, Global Affairs Canada (GAC)
    and 1 more
    • David Jean-Laniel · Directeur adjoint, Global Affairs Canada (GAC)
    Policies aimed at reinforcing pharmaceutical supply chain. Read more

    Improvements to the supports offered by the federal government to support R&D; in particular, generic drug research and development.

    Official report

  • Pharmascience Inc.
    • Celia Lourenco · Sous-ministre adjointe déléguée, Health Canada (HC)
    • Greg Loyst · Directeur général, Health Canada (HC)
    • Sven Schirmer · Sous-ministre adjoint, Health Canada (HC)
    Policies aimed at reinforcing pharmaceutical supply chain. Read more

    Improvements to the supports offered by the federal government to support R&D; in particular, generic drug research and development.

    Official report

  • Pharmascience Inc.
    • Jocelyn Milburn · Directrice, Innovation, Science and Economic Development Canada (ISED)
    Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.

    Official report

  • Pharmascience Inc.
    • Jocelyn Milburn · Directrice, Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia · Directeur général, Innovation, Science and Economic Development Canada (ISED)
    Policies aimed at reinforcing pharmaceutical supply chain.

    Official report

  • Pharmascience Inc.
    • Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    • Jocelyn Milburn · Directrice, Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia · Directeur général, Innovation, Science and Economic Development Canada (ISED)
    Policies aimed at reinforcing pharmaceutical supply chain. Read more

    Improvements to the supports offered by the federal government to support R&D; in particular, generic drug research and development.

    Official report

  • Pharmascience Inc.
    • Patrick Halley · Sous-ministre adjoint, Finance Canada (FIN)
    • Samuel Millar · Sous-ministre adjoint délégué, Finance Canada (FIN)
    Policies aimed at reinforcing pharmaceutical supply chain. Read more

    Improvements to the supports offered by the federal government to support R&D; in particular, generic drug research and development.

    Official report

  • Pharmascience Inc.
    • Jamee St-Hilaire · Québec Lieutenant's office, Health Canada (HC)

    HealthIndustry

    Official report

  • Pharmascience Inc.

    HealthIndustry

    Official report

  • Pharmascience Inc.
    • Eric Costen · Assistant Deputy Minister, Industry, Science and Economic Development Canada, Innovation, Science and Economic Development Canada (ISED)

    HealthIndustry

    Official report

  • Pharmascience Inc.
    • Jamie Kippen · Chef de cabinet, Health Canada (HC)

    HealthIndustry

    Official report

  • Pharmascience Inc.
    • Ian Foucher · Chef de cabinet, Innovation, Science and Economic Development Canada (ISED)
    • Bianca Hossain · Adjoint(e) principale spécial(e), Innovation, Science and Economic Development Canada (ISED)

    HealthIndustry

    Official report

  • Pharmascience Inc.
    • Bianca Hossain · Sr Special Assistant, Innovation, Science and Economic Development Canada (ISED)

    HealthIndustry

    Official report

  • Pharmascience Inc.

    HealthIndustry

    Official report

  • Pharmascience Inc.
    • Shaili Patel · Director of Policy, Health Canada (HC)

    Health

    Official report

  • Pharmascience Inc.
    • Bianca Hossain · Sr Special Assistant, Innovation, Science and Economic Development Canada (ISED)

    Economic DevelopmentHealthIndustry

    Official report

  • Pharmascience Inc.
    • Sandenga Yeba · Senior Policy Advisor, Health Canada (HC)
    • Victor Kandasamy · Policy Advisor (Quebec), Health Canada (HC)

    HealthIndustry

    Official report

  • Pharmascience Inc.
    • Stephen Lucas · Deputy Minister, Health Canada (HC)

    HealthIndustry

    Official report

  • Pharmascience Inc.
    • Simon Kennedy · Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    • Eric Costen · Assistant Deputy Minister, Industry, Science and Economic Development Canada, Innovation, Science and Economic Development Canada (ISED)

    Economic DevelopmentHealthIndustry

    Official report

  • Pharmascience Inc.
    • Majid Jowhari · Member of Parliament, House of Commons

    Health

    Official report

  • Pharmascience Inc.

    Health

    Official report

  • Pharmascience Inc.

    Health

    Official report

  • Pharmascience Inc.
    • Sandenga Yeba · Senior Policy Advisor, Health Canada (HC)

    HealthIndustry

    Official report

  • Pharmascience Inc.

    Economic DevelopmentHealthIndustry

    Official report

  • Pharmascience Inc.
    • Matthew Stenson · Policy Advisor, Global Affairs Canada (GAC)

    Government ProcurementHealth

    Official report

  • Pharmascience Inc.
    • Laurence Harvey · Senior Policy Advisor, Global Affairs Canada (GAC)
    • Camille Benoit-Blouin · Policy Advisor, Global Affairs Canada (GAC)

    HealthInternational Trade

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.